|
Addlife AB (0Rez.L) Valoración de DCF
SE | Healthcare | Medical - Pharmaceuticals | LSE
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
AddLife AB (publ) (0REZ.L) Bundle
Ingementista para su precisión, nuestra calculadora DCF (0REZL) le permite evaluar la valoración de AddLife AB (Publ) utilizando información financiera del mundo real al tiempo que proporciona flexibilidad completa para modificar todos los parámetros esenciales para las proyecciones mejoradas.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5,273.3 | 7,992.6 | 9,084.0 | 9,685.0 | 10,286.0 | 12,292.9 | 14,691.4 | 17,557.8 | 20,983.5 | 25,077.6 |
| Revenue Growth, % | 0 | 51.57 | 13.66 | 6.62 | 6.21 | 19.51 | 19.51 | 19.51 | 19.51 | 19.51 |
| EBITDA | 951.0 | 1,464.6 | 1,450.0 | 1,546.0 | 721.0 | 1,851.1 | 2,212.3 | 2,644.0 | 3,159.8 | 3,776.3 |
| EBITDA, % | 18.03 | 18.32 | 15.96 | 15.96 | 7.01 | 15.06 | 15.06 | 15.06 | 15.06 | 15.06 |
| Depreciation | 274.2 | 478.4 | 722.0 | 919.0 | .0 | 703.7 | 841.0 | 1,005.1 | 1,201.2 | 1,435.6 |
| Depreciation, % | 5.2 | 5.99 | 7.95 | 9.49 | 0 | 5.72 | 5.72 | 5.72 | 5.72 | 5.72 |
| EBIT | 676.8 | 986.2 | 728.0 | 627.0 | 721.0 | 1,147.4 | 1,371.3 | 1,638.9 | 1,958.6 | 2,340.8 |
| EBIT, % | 12.83 | 12.34 | 8.01 | 6.47 | 7.01 | 9.33 | 9.33 | 9.33 | 9.33 | 9.33 |
| Total Cash | 216.0 | 345.3 | 376.0 | 272.0 | 331.0 | 456.9 | 546.0 | 652.5 | 779.8 | 932.0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 795.6 | 1,166.5 | 1,351.0 | 1,485.0 | .0 | 1,472.4 | 1,759.7 | 2,103.0 | 2,513.3 | 3,003.7 |
| Account Receivables, % | 15.09 | 14.59 | 14.87 | 15.33 | 0 | 11.98 | 11.98 | 11.98 | 11.98 | 11.98 |
| Inventories | 640.2 | 1,188.5 | 1,646.0 | 1,653.0 | 1,724.0 | 1,941.3 | 2,320.0 | 2,772.7 | 3,313.6 | 3,960.2 |
| Inventories, % | 12.14 | 14.87 | 18.12 | 17.07 | 16.76 | 15.79 | 15.79 | 15.79 | 15.79 | 15.79 |
| Accounts Payable | 648.8 | 796.0 | 957.0 | 981.0 | .0 | 1,055.4 | 1,261.3 | 1,507.4 | 1,801.5 | 2,153.0 |
| Accounts Payable, % | 12.3 | 9.96 | 10.54 | 10.13 | 0 | 8.59 | 8.59 | 8.59 | 8.59 | 8.59 |
| Capital Expenditure | -92.2 | -143.9 | -282.0 | -226.0 | .0 | -220.9 | -264.1 | -315.6 | -377.1 | -450.7 |
| Capital Expenditure, % | -1.75 | -1.8 | -3.1 | -2.33 | 0 | -1.8 | -1.8 | -1.8 | -1.8 | -1.8 |
| Tax Rate, % | 37.78 | 37.78 | 37.78 | 37.78 | 37.78 | 37.78 | 37.78 | 37.78 | 37.78 | 37.78 |
| EBITAT | 531.8 | 764.8 | 580.5 | 351.4 | 448.6 | 812.7 | 971.2 | 1,160.7 | 1,387.2 | 1,657.9 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -73.2 | 327.3 | 539.5 | 927.4 | 881.6 | 661.2 | 1,088.1 | 1,300.4 | 1,554.1 | 1,857.3 |
| WACC, % | 10.71 | 10.71 | 10.71 | 10.71 | 10.71 | 10.71 | 10.71 | 10.71 | 10.71 | 10.71 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 4,594.6 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 1,894 | |||||||||
| Terminal Value | 21,753 | |||||||||
| Present Terminal Value | 13,080 | |||||||||
| Enterprise Value | 17,674 | |||||||||
| Net Debt | -331 | |||||||||
| Equity Value | 18,005 | |||||||||
| Diluted Shares Outstanding, MM | 122 | |||||||||
| Equity Value Per Share | 147.75 |
Benefits of Choosing AddLife AB (0REZL)
- Comprehensive Financial Model: Leverage AddLife AB’s actual performance data for accurate DCF evaluations.
- Complete Forecast Flexibility: Modify revenue growth, profit margins, WACC, and other essential drivers as needed.
- Real-Time Calculations: Automatic updates allow you to view the outcome instantly as you adjust inputs.
- Professional-Grade Template: A polished Excel file crafted for high-quality valuation presentations.
- Customizable and Versatile: Designed for adaptability, making it suitable for repeated in-depth forecasting.
Key Features
- Accurate Financial Data for AddLife AB: Gain access to reliable historical data and future forecasts tailored for [0REZL].
- Flexible Forecast Inputs: Customize highlighted fields such as WACC, growth rates, and profit margins to suit your analysis.
- Instantaneous Calculations: Real-time updates for DCF, Net Present Value (NPV), and cash flow assessments.
- User-Friendly Dashboard: Intuitive charts and summaries designed to help you visualize your valuation outcomes effectively.
- Designed for All Skill Levels: An accessible format suitable for investors, CFOs, and consultants alike.
How It Works
- 1. Access the Template: Download and open the Excel file featuring AddLife AB (publ) [0REZL] preloaded data.
- 2. Modify Assumptions: Adjust key inputs such as growth projections, WACC, and capital expenditure.
- 3. View Results in Real-Time: The DCF model automatically computes intrinsic value and NPV based on your inputs.
- 4. Explore Scenarios: Evaluate various forecasts to investigate different valuation possibilities.
- 5. Present with Assurance: Share professional valuation insights to enhance your decision-making process.
Why Opt for This Calculator?
- Precision: Utilizing accurate financial data from AddLife AB (publ) ensures reliable calculations.
- Versatility: Tailored for users to experiment with and adjust inputs as needed.
- Efficiency: Eliminate the challenge of constructing a DCF model from the ground up.
- Executive-Quality: Created with the insight and usability expected at the CFO level.
- Intuitive: Simple to navigate, making it accessible for individuals lacking advanced financial modeling skills.
Who Should Benefit from This Product?
- Professional Investors: Create comprehensive and trustworthy valuation models for portfolio assessment.
- Corporate Finance Departments: Evaluate valuation scenarios to inform strategic decisions.
- Consultants and Advisors: Offer clients precise valuation insights for AddLife AB (publ) (0REZL) stock.
- Students and Educators: Leverage real-world data to learn and teach financial modeling techniques.
- Healthcare Industry Enthusiasts: Gain insights into how companies like AddLife AB (publ) (0REZL) are valued in the market.
Contents of the Template
- Operating and Balance Sheet Data: Pre-filled historical data and forecasts for AddLife AB (publ) (0REZL), including metrics such as revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for calculating the Weighted Average Cost of Capital (WACC), featuring key parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Customizable Discounted Cash Flow models that provide intrinsic value assessments along with comprehensive calculations.
- Financial Statements: Pre-loaded annual and quarterly financial statements to facilitate thorough analysis.
- Key Ratios: A collection of profitability, leverage, and efficiency ratios specific to AddLife AB (publ) (0REZL).
- Dashboard and Charts: Visual summaries of valuation results and assumptions to aid in the analysis of outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.